相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reward, Addiction, Withdrawal to Nicotine
Mariella De Biasi et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice
Dena Kota et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
Sonal Singh et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Modulation of the Ca2+ permeability of human endplate acetylcholine receptor-channel
Vanessa Piccari et al.
CELL CALCIUM (2011)
Design, Synthesis, and Pharmacological Characterization of Novel Spirocyclic Quinuclidinyl-Δ2-Isoxazoline Derivatives as Potent and Selective Agonists of α7 Nicotinic Acetylcholine Receptors
Clelia Dallanoce et al.
CHEMMEDCHEM (2011)
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2*nicotinic acetylcholine receptors
Luca Pucci et al.
FASEB JOURNAL (2011)
Unichiral 2-(2′-Pyrrolidinyl)-1,4-benzodioxanes: the 2R,2′S Diastereomer of the N-Methyl-7-hydroxy Analogue Is a Potent α4β2-and α6β2-Nicotinic Acetylcholine Receptor Partial Agonist
Cristiano Bolchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Intravenous nicotine self-administration and cue-induced reinstatement in mice: Effects of nicotine dose, rate of drug infusion and prior instrumental training
Christie D. Fowler et al.
NEUROPHARMACOLOGY (2011)
Partial Agonists of the α3β4*Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats
Susmita Chatterjee et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Suicidal Behavior and Depression in Smoking Cessation Treatments
Thomas J. Moore et al.
PLOS ONE (2011)
α6β2*and α4β2*Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Maryka Quik et al.
PHARMACOLOGICAL REVIEWS (2011)
Nicotine receptor partial agonists for smoking cessation
Kate Cahill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Varenicline Is a Potent Agonist of the Human 5-Hydroxytryptamine3 Receptor
S. C. R. Lummis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
86Rb+ efflux mediated by α4β2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization
Michael J. Marks et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence
H. Rollema et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Jean-Pierre Changeux
NATURE REVIEWS NEUROSCIENCE (2010)
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats
Grazyna Biala et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
Eoin C. O'Connor et al.
PSYCHOPHARMACOLOGY (2010)
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Yann S. Mineur et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Nicotinic acetylcholine receptors and the ascending dopamine pathways
Phil D. Livingstone et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Structural and functional diversity of native brain neuronal nicotinic receptors
Cecilia Gotti et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
Sherry A. McKee et al.
BIOLOGICAL PSYCHIATRY (2009)
Rodent Habenulo-Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the α3β4*and α3β3β4*Subtypes Mediate Acetylcholine Release
Sharon R. Grady et al.
JOURNAL OF NEUROSCIENCE (2009)
Involvement of κ-opioid and endocannabinoid system on salvinorin A-induced reward
Daniela Braida et al.
BIOLOGICAL PSYCHIATRY (2008)
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation
Piotr Tutka
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Exacerbation of schizophrenia by varenicline
Robert Freedman
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation
Hans Rollema et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Pharmacology of α-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice
Outi Salminen et al.
MOLECULAR PHARMACOLOGY (2007)
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
H. Rollema et al.
NEUROPHARMACOLOGY (2007)
Oral varenicline for smoking cessation
Seena L. Zierler-Brown et al.
ANNALS OF PHARMACOTHERAPY (2007)
Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes
Layla Azam et al.
MOLECULAR PHARMACOLOGY (2006)
Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors
Karla B. Mihalak et al.
MOLECULAR PHARMACOLOGY (2006)
Nicotine replacement therapy for long-term smoking cessation: a meta-analysis
Jean-Francois Etter et al.
TOBACCO CONTROL (2006)
The human adult subtype ACh receptor channel has high Ca2+ permeability and predisposes to endplate Ca2+ overloading
Sergio Fucile et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline
J Foulds
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Cecilia Gotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
JW Coe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats
D Braida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice
O Salminen et al.
MOLECULAR PHARMACOLOGY (2004)
Fractional Ca2+ current through human neuronal α7 nicotinic acetylcholine receptors
S Fucile et al.
CELL CALCIUM (2003)
Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes
E Carbonnelle et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice
NS Wang et al.
PROGRESS IN NEUROBIOLOGY (2002)
Ca2+ permeability of human heteromeric nAChRs expressed by transfection in human cells
P Lax et al.
CELL CALCIUM (2002)
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum
SR Grady et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system
D Braida et al.
NEUROSCIENCE (2001)
分享论文
